Research News

On Friday, July 24th, REPRIEVE held its first ever Virtual Meeting with  nearly 300 virtual attendees! We heard a keynote presentation from Dr. Sandra Wanger Cordoso on HIV and CVD risk in Brazil, and 3 additional presentations from REPRIEVE Co-Investigators Dr. Kristine Erlandson, Dr. Turner Overton, and Dr. Carl Fichtenbaum, presenting their findings from their respective manuscripts in the JID supplement. If you were unable to join us, the event is available for viewing at the following link: http://healthcare.partners.org/streaming/Live/MGH/2020.07.24_REPRIEVE_Meeting.html

 

HPTN-Covid-19-resource-center

HPTN-083-study-demonstrates-superiority-cabotegravir-prevention-hiv

Understanding the spread of HIV in women

Half of Atlanta's newly diagnosed HIV patients have AIDS

Atlanta ranked #1 in new cases of HIV/AIDS